Back to Agenda
DIA Global Annual Meeting – Opening DIAmond and Plenary Session
Session Chair(s)
Barbara Lopez Kunz, MBA, MS, MSc
Director | Advisor | CEO
United States
We are excited to welcome you to the DIA 2020 Virtual Global Annual Meeting
Join us for the Global Annual Meeting Welcome Remarks, Keynote Address, and Opening DIAmond Session!
Keynote Address: Confessions of a "Human Subject" - Can We Put the Humanity in Scientific Study?
When Mary Elizabeth Williams was diagnosed with metastatic cancer and trying to get into an odds-defying clinical trial, a clinician at her hospital casually introduced her to his research fellows as "the tumor." Science is advancing, but what good is it if patients feel alienated? Journalist and author Williams will discuss why the treatment plan process must understand the emotional and logistical needs of the patient, and how humanity is an essential element of successful healthcare outcomes.
DIAmond Session:
In this thought-provoking session, top leaders will discuss how the COVID-19 crisis is shaping the future of drug development. They will look back on the world’s response to the pandemic and what that has revealed about our preparedness to manage a crisis of this proportion. How will learnings be applied in the post-COVID environment? The panel will discuss forward-looking efforts being implemented and how collaboration and innovative thinking will be crucial to our ability to better prepare for “the next time.”
Learning Objective : Discuss why treatment plans must address the emotional and logistical needs of the patient in advancing science; Identify how forward-looking efforts are shaping the future of drug development as a result of the COVID-19 crisis; Evaluate how collaborative and innovative thinking can better prepare for next pandemic.
Speaker(s)
Honorary Chair
Michelle Rohrer, PhD
Roche, United States
Senior Vice President, Global Head of Product Development Regulatory and Policy
Keynote Address
Maryelizabeth Williams
maryelizabethwilliams.net, United States
Writer, Speaker, Consultant
DIAmond Session: Emerging from the COVID-19 Crisis: Innovation Will Not Be Optional
Elizabeth Garner, MD, MPH
Ferring Pharmaceuticals Inc., United States
Chief Scientific Officer
Panelist
Dalvir Gill, PhD
TransCelerate BioPharma Inc., United States
Chief Executive Officer
Panelist
Michelle Rohrer, PhD
Roche, United States
Senior Vice President, Global Head of Product Development Regulatory and Policy
Panelist
Rod MacKenzie, PhD
Pfizer Inc, United States
Executive Vice President, Chief Development Officer
Panelist
Christopher P. Austin, MD
Flagship Pioneering, United States
CEO Partner
Panelist
Doris Rouse, PhD
RTI International, United States
Vice President, Global Health Technologies
Have an account?